Related Experiment Video
Updated: Jul 1, 2026
07:50
A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
Hypocretin (orexin) deficiency in human narcolepsy
Lancet (London, England)
|January 1, 2000
Abstract:
Alterations in the hypocretin receptor 2 and preprohypocretin genes produce narcolepsy in animal models. Hypocretin was undetectable in seven out of nine people with narcolepsy, indicating abnormal hypocretin transmission.
Insights
Narcolepsy in humans is linked to abnormal hypocretin transmission. Studies show genetic changes affecting hypocretin receptors and genes cause narcolepsy in animals, with hypocretin undetectable in most narcolepsy patients.
Area of Science:
- Neuroscience
- Genetics
- Sleep Medicine
Background:
- Narcolepsy is a chronic neurological disorder affecting the brain's ability to regulate sleep-wake cycles.
- Genetic factors, specifically alterations in hypocretin receptor 2 (HCRT2) and preprohypocretin (PPHO) genes, have been implicated in narcolepsy pathogenesis in animal models.
Discussion:
- The study investigates the role of hypocretin signaling in human narcolepsy.
- Findings suggest a potential link between genetic predispositions and hypocretin deficiency in narcolepsy patients.
- Abnormal hypocretin transmission is a key feature observed in the majority of individuals with narcolepsy.
Key Insights:
- Genetic mutations in HCRT2 and PPHO genes are sufficient to induce narcolepsy-like symptoms in animal models.
- Hypocretin neuropeptides were found to be undetectable in 7 out of 9 human narcolepsy cases.
- This highlights the critical role of the hypocretin system in maintaining normal sleep-wakefulness in humans.
Outlook:
- Further research is warranted to fully elucidate the genetic and molecular mechanisms underlying hypocretin deficiency in narcolepsy.
- Developing targeted therapies aimed at restoring hypocretin signaling could offer new treatment avenues for narcolepsy.
- Understanding these pathways may also shed light on other sleep disorders.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:30Toxidromes: Clinical Features
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
01:17Sleepwalking and Sleep Talking
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:28Depressants
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...